The management of tics
Identifieur interne : 002882 ( Main/Merge ); précédent : 002881; suivant : 002883The management of tics
Auteurs : David Shprecher [États-Unis] ; Roger Kurlan [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2009-01-15.
English descriptors
- KwdEn :
- ADHD, Adolescent, Adrenergic alpha-Agonists (therapeutic use), Adult, Antipsychotic Agents (therapeutic use), Attention Deficit Disorder with Hyperactivity (complications), Attention Deficit Disorder with Hyperactivity (drug therapy), Behavior Therapy, Botulinum Toxins, Type A (therapeutic use), Brain Diseases (complications), Child, Combined Modality Therapy, Deep Brain Stimulation, Diagnosis, Differential, Disease Management, Dopamine Agents (therapeutic use), Drug Therapy, Combination, Humans, Mental Disorders (complications), OCD, Obsessive-Compulsive Disorder (complications), Obsessive-Compulsive Disorder (drug therapy), Patient Education as Topic, Stereotypic Movement Disorder (diagnosis), Tics (diagnosis), Tics (drug therapy), Tics (etiology), Tics (physiopathology), Tics (therapy), Tourette's syndrome, tics.
- MESH :
- chemical , therapeutic use : Adrenergic alpha-Agonists, Antipsychotic Agents, Botulinum Toxins, Type A, Dopamine Agents.
- complications : Attention Deficit Disorder with Hyperactivity, Brain Diseases, Mental Disorders, Obsessive-Compulsive Disorder.
- diagnosis : Stereotypic Movement Disorder, Tics.
- drug therapy : Attention Deficit Disorder with Hyperactivity, Obsessive-Compulsive Disorder, Tics.
- etiology : Tics.
- physiopathology : Tics.
- therapy : Tics.
- Adolescent, Adult, Behavior Therapy, Child, Combined Modality Therapy, Deep Brain Stimulation, Diagnosis, Differential, Disease Management, Drug Therapy, Combination, Humans, Patient Education as Topic.
Abstract
A tic is a stereotyped repetitive involuntary movement or sound, frequently preceded by premonitory sensations or urges. Most tic disorders are genetic or idiopathic in nature, possibly due to a developmental failure of inhibitory function within frontal‐subcortical circuits modulating volitional movements. Currently available oral medications can reduce the severity of tics, but rarely eliminate them. Botulinum toxin injections can be effective if there are a few particularly disabling motor tics. Deep brain stimulation has been reported to be an effective treatment for the most severe cases, but remains unproven. A comprehensive evaluation accounting for secondary causes, psychosocial factors, and comorbid neuropsychiatric conditions is essential to successful treatment of tic disorders. © 2008 Movement Disorder Society
Url:
- https://api.istex.fr/document/3E972DED523195D9FB6BCAD9969063A146640CD2/fulltext/pdf
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701289
DOI: 10.1002/mds.22378
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001369
- to stream Istex, to step Curation: 001369
- to stream Istex, to step Checkpoint: 000C23
- to stream Pmc, to step Corpus: 000048
- to stream Pmc, to step Curation: 000048
- to stream Pmc, to step Checkpoint: 000387
- to stream PubMed, to step Corpus: 001E60
- to stream PubMed, to step Curation: 001E60
- to stream PubMed, to step Checkpoint: 001B35
- to stream Ncbi, to step Merge: 002504
- to stream Ncbi, to step Curation: 002504
- to stream Ncbi, to step Checkpoint: 002504
Links to Exploration step
ISTEX:3E972DED523195D9FB6BCAD9969063A146640CD2Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The management of tics</title><author><name sortKey="Shprecher, David" sort="Shprecher, David" uniqKey="Shprecher D" first="David" last="Shprecher">David Shprecher</name></author><author><name sortKey="Kurlan, Roger" sort="Kurlan, Roger" uniqKey="Kurlan R" first="Roger" last="Kurlan">Roger Kurlan</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:3E972DED523195D9FB6BCAD9969063A146640CD2</idno><date when="2009" year="2009">2009</date><idno type="doi">10.1002/mds.22378</idno><idno type="url">https://api.istex.fr/document/3E972DED523195D9FB6BCAD9969063A146640CD2/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001369</idno><idno type="wicri:Area/Istex/Curation">001369</idno><idno type="wicri:Area/Istex/Checkpoint">000C23</idno><idno type="wicri:doubleKey">0885-3185:2009:Shprecher D:the:management:of</idno><idno type="wicri:source">PMC</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701289</idno><idno type="RBID">PMC:2701289</idno><idno type="wicri:Area/Pmc/Corpus">000048</idno><idno type="wicri:Area/Pmc/Curation">000048</idno><idno type="wicri:Area/Pmc/Checkpoint">000387</idno><idno type="wicri:source">PubMed</idno><idno type="wicri:Area/PubMed/Corpus">001E60</idno><idno type="wicri:Area/PubMed/Curation">001E60</idno><idno type="wicri:Area/PubMed/Checkpoint">001B35</idno><idno type="wicri:Area/Ncbi/Merge">002504</idno><idno type="wicri:Area/Ncbi/Curation">002504</idno><idno type="wicri:Area/Ncbi/Checkpoint">002504</idno><idno type="wicri:doubleKey">0885-3185:2009:Shprecher D:the:management:of</idno><idno type="wicri:Area/Main/Merge">002882</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">The management of tics</title><author><name sortKey="Shprecher, David" sort="Shprecher, David" uniqKey="Shprecher D" first="David" last="Shprecher">David Shprecher</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Department of Neurology, University of Rochester School of Medicine and Dentistry, 1351 Mt. Hope Avenue, Suite 100, Rochester</wicri:cityArea></affiliation></author><author><name sortKey="Kurlan, Roger" sort="Kurlan, Roger" uniqKey="Kurlan R" first="Roger" last="Kurlan">Roger Kurlan</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Department of Neurology, University of Rochester School of Medicine and Dentistry, 1351 Mt. Hope Avenue, Suite 100, Rochester</wicri:cityArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2009-01-15">2009-01-15</date><biblScope unit="vol">24</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="15">15</biblScope><biblScope unit="page" to="24">24</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">3E972DED523195D9FB6BCAD9969063A146640CD2</idno><idno type="DOI">10.1002/mds.22378</idno><idno type="ArticleID">MDS22378</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>ADHD</term><term>Adolescent</term><term>Adrenergic alpha-Agonists (therapeutic use)</term><term>Adult</term><term>Antipsychotic Agents (therapeutic use)</term><term>Attention Deficit Disorder with Hyperactivity (complications)</term><term>Attention Deficit Disorder with Hyperactivity (drug therapy)</term><term>Behavior Therapy</term><term>Botulinum Toxins, Type A (therapeutic use)</term><term>Brain Diseases (complications)</term><term>Child</term><term>Combined Modality Therapy</term><term>Deep Brain Stimulation</term><term>Diagnosis, Differential</term><term>Disease Management</term><term>Dopamine Agents (therapeutic use)</term><term>Drug Therapy, Combination</term><term>Humans</term><term>Mental Disorders (complications)</term><term>OCD</term><term>Obsessive-Compulsive Disorder (complications)</term><term>Obsessive-Compulsive Disorder (drug therapy)</term><term>Patient Education as Topic</term><term>Stereotypic Movement Disorder (diagnosis)</term><term>Tics (diagnosis)</term><term>Tics (drug therapy)</term><term>Tics (etiology)</term><term>Tics (physiopathology)</term><term>Tics (therapy)</term><term>Tourette's syndrome</term><term>tics</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Adrenergic alpha-Agonists</term><term>Antipsychotic Agents</term><term>Botulinum Toxins, Type A</term><term>Dopamine Agents</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Attention Deficit Disorder with Hyperactivity</term><term>Brain Diseases</term><term>Mental Disorders</term><term>Obsessive-Compulsive Disorder</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Stereotypic Movement Disorder</term><term>Tics</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Attention Deficit Disorder with Hyperactivity</term><term>Obsessive-Compulsive Disorder</term><term>Tics</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Tics</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Tics</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Tics</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Behavior Therapy</term><term>Child</term><term>Combined Modality Therapy</term><term>Deep Brain Stimulation</term><term>Diagnosis, Differential</term><term>Disease Management</term><term>Drug Therapy, Combination</term><term>Humans</term><term>Patient Education as Topic</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A tic is a stereotyped repetitive involuntary movement or sound, frequently preceded by premonitory sensations or urges. Most tic disorders are genetic or idiopathic in nature, possibly due to a developmental failure of inhibitory function within frontal‐subcortical circuits modulating volitional movements. Currently available oral medications can reduce the severity of tics, but rarely eliminate them. Botulinum toxin injections can be effective if there are a few particularly disabling motor tics. Deep brain stimulation has been reported to be an effective treatment for the most severe cases, but remains unproven. A comprehensive evaluation accounting for secondary causes, psychosocial factors, and comorbid neuropsychiatric conditions is essential to successful treatment of tic disorders. © 2008 Movement Disorder Society</div></front></TEI><double doi="10.1002/mds.22378"><ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The management of tics</title><author><name sortKey="Shprecher, David" sort="Shprecher, David" uniqKey="Shprecher D" first="David" last="Shprecher">David Shprecher</name></author><author><name sortKey="Kurlan, Roger" sort="Kurlan, Roger" uniqKey="Kurlan R" first="Roger" last="Kurlan">Roger Kurlan</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:3E972DED523195D9FB6BCAD9969063A146640CD2</idno><date when="2009" year="2009">2009</date><idno type="doi">10.1002/mds.22378</idno><idno type="url">https://api.istex.fr/document/3E972DED523195D9FB6BCAD9969063A146640CD2/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001369</idno><idno type="wicri:Area/Istex/Curation">001369</idno><idno type="wicri:Area/Istex/Checkpoint">000C23</idno><idno type="wicri:doubleKey">0885-3185:2009:Shprecher D:the:management:of</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">The management of tics</title><author><name sortKey="Shprecher, David" sort="Shprecher, David" uniqKey="Shprecher D" first="David" last="Shprecher">David Shprecher</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Department of Neurology, University of Rochester School of Medicine and Dentistry, 1351 Mt. Hope Avenue, Suite 100, Rochester</wicri:cityArea></affiliation></author><author><name sortKey="Kurlan, Roger" sort="Kurlan, Roger" uniqKey="Kurlan R" first="Roger" last="Kurlan">Roger Kurlan</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Department of Neurology, University of Rochester School of Medicine and Dentistry, 1351 Mt. Hope Avenue, Suite 100, Rochester</wicri:cityArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2009-01-15">2009-01-15</date><biblScope unit="vol">24</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="15">15</biblScope><biblScope unit="page" to="24">24</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">3E972DED523195D9FB6BCAD9969063A146640CD2</idno><idno type="DOI">10.1002/mds.22378</idno><idno type="ArticleID">MDS22378</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>ADHD</term><term>OCD</term><term>Tourette's syndrome</term><term>tics</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A tic is a stereotyped repetitive involuntary movement or sound, frequently preceded by premonitory sensations or urges. Most tic disorders are genetic or idiopathic in nature, possibly due to a developmental failure of inhibitory function within frontal‐subcortical circuits modulating volitional movements. Currently available oral medications can reduce the severity of tics, but rarely eliminate them. Botulinum toxin injections can be effective if there are a few particularly disabling motor tics. Deep brain stimulation has been reported to be an effective treatment for the most severe cases, but remains unproven. A comprehensive evaluation accounting for secondary causes, psychosocial factors, and comorbid neuropsychiatric conditions is essential to successful treatment of tic disorders. © 2008 Movement Disorder Society</div></front></TEI></ISTEX><PMC><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The Management of Tics</title><author><name sortKey="Shprecher, David" sort="Shprecher, David" uniqKey="Shprecher D" first="David" last="Shprecher">David Shprecher</name></author><author><name sortKey="Kurlan, Roger" sort="Kurlan, Roger" uniqKey="Kurlan R" first="Roger" last="Kurlan">Roger Kurlan</name></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">19170198</idno><idno type="pmc">2701289</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701289</idno><idno type="RBID">PMC:2701289</idno><idno type="doi">10.1002/mds.22378</idno><date when="2009">2009</date><idno type="wicri:Area/Pmc/Corpus">000048</idno><idno type="wicri:Area/Pmc/Curation">000048</idno><idno type="wicri:Area/Pmc/Checkpoint">000387</idno><idno type="wicri:source">PubMed</idno><idno type="wicri:Area/PubMed/Corpus">001E60</idno><idno type="wicri:Area/PubMed/Curation">001E60</idno><idno type="wicri:Area/PubMed/Checkpoint">001B35</idno><idno type="wicri:Area/Ncbi/Merge">002504</idno><idno type="wicri:Area/Ncbi/Curation">002504</idno><idno type="wicri:Area/Ncbi/Checkpoint">002504</idno><idno type="wicri:doubleKey">0885-3185:2009:Shprecher D:the:management:of</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">The Management of Tics</title><author><name sortKey="Shprecher, David" sort="Shprecher, David" uniqKey="Shprecher D" first="David" last="Shprecher">David Shprecher</name></author><author><name sortKey="Kurlan, Roger" sort="Kurlan, Roger" uniqKey="Kurlan R" first="Roger" last="Kurlan">Roger Kurlan</name></author></analytic><series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><date when="2009">2009</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adrenergic alpha-Agonists (therapeutic use)</term><term>Adult</term><term>Antipsychotic Agents (therapeutic use)</term><term>Attention Deficit Disorder with Hyperactivity (complications)</term><term>Attention Deficit Disorder with Hyperactivity (drug therapy)</term><term>Behavior Therapy</term><term>Botulinum Toxins, Type A (therapeutic use)</term><term>Brain Diseases (complications)</term><term>Child</term><term>Combined Modality Therapy</term><term>Deep Brain Stimulation</term><term>Diagnosis, Differential</term><term>Disease Management</term><term>Dopamine Agents (therapeutic use)</term><term>Drug Therapy, Combination</term><term>Humans</term><term>Mental Disorders (complications)</term><term>Obsessive-Compulsive Disorder (complications)</term><term>Obsessive-Compulsive Disorder (drug therapy)</term><term>Patient Education as Topic</term><term>Stereotypic Movement Disorder (diagnosis)</term><term>Tics (diagnosis)</term><term>Tics (drug therapy)</term><term>Tics (etiology)</term><term>Tics (physiopathology)</term><term>Tics (therapy)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Adrenergic alpha-Agonists</term><term>Antipsychotic Agents</term><term>Botulinum Toxins, Type A</term><term>Dopamine Agents</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Attention Deficit Disorder with Hyperactivity</term><term>Brain Diseases</term><term>Mental Disorders</term><term>Obsessive-Compulsive Disorder</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Stereotypic Movement Disorder</term><term>Tics</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Attention Deficit Disorder with Hyperactivity</term><term>Obsessive-Compulsive Disorder</term><term>Tics</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Tics</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Tics</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Tics</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Behavior Therapy</term><term>Child</term><term>Combined Modality Therapy</term><term>Deep Brain Stimulation</term><term>Diagnosis, Differential</term><term>Disease Management</term><term>Drug Therapy, Combination</term><term>Humans</term><term>Patient Education as Topic</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p id="P1">A tic is a stereotyped repetitive involuntary movement or sound, frequently preceded by premonitory sensations or urges. Most tic disorders are genetic or idiopathic in nature, possibly due to a developmental failure of inhibitory function within frontal-subcortical circuits modulating volitional movements. Currently available oral medications can reduce the severity of tics, but rarely eliminate them. Botulinum toxin injections can be effective if there are a few particularly disabling motor tics. Deep brain stimulation has been reported to be an effective treatment for the most severe cases, but remains unproven. A comprehensive evaluation accounting for secondary causes, psychosocial factors, and comorbid neuropsychiatric conditions is essential to successful treatment of tic disorders.</p></div></front></TEI></PMC></double></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002882 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 002882 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Merge
|type= RBID
|clé= ISTEX:3E972DED523195D9FB6BCAD9969063A146640CD2
|texte= The management of tics
}}
| This area was generated with Dilib version V0.6.23. |  |